Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MDxHealth SA - Ordinary Shares (NQ: MDXH )

2.000 +0.040 (+2.04%)
Streaming Delayed Price Updated: 12:59 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MDxHealth SA - Ordinary Shares

< Previous 1 2 Next >
MDxHealth to Participate in Piper Sandler Healthcare Conference
From mdxhealth
Via GlobeNewswire
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
From mdxhealth
Via GlobeNewswire
MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6
From mdxhealth
Via GlobeNewswire
Dow Surges Over 250 Points; Accenture Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
BTIG Maintains Buy Rating for MDxHealth: Here's What You Need To Know
Via Benzinga
Crude Oil Down Over 2%; US Initial Jobless Claims Fall
Via Benzinga
Exposures Fossil Fuels
Nasdaq Gains Over 1%; Micron Posts Upbeat Q4 Results
Via Benzinga
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MDxHealth Announces Pricing of Offering of Ordinary Shares
From mdxhealth
Via GlobeNewswire
MDxHealth Announces Launch of Offering of Ordinary Shares
From mdxhealth
Via GlobeNewswire
MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q2 2024
MDXH stock results show that MDxHealth missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
MDxHealth Reports Q2 and Half Year 2024 Results
From mdxhealth
Via GlobeNewswire
MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21
From mdxhealth
Via GlobeNewswire
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance
From mdxhealth
Via GlobeNewswire
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors
From mdxhealth
Via GlobeNewswire
Mdxhealth to Present at Upcoming Investor Conferences
From mdxhealth
Via GlobeNewswire
MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q1 2024
MDXH stock results show that MDxHealth missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
From mdxhealth
Via GlobeNewswire
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
From mdxhealth
Via GlobeNewswire
These Analysts Increase Their Forecasts On MDxHealth After Q4 Results
MDxHealth SA (NASDAQ: MDXH) reported better-than-expected sales for its fourth quarter on Wednesday. 
Via Benzinga
Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
From mdxhealth
Via GlobeNewswire
MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6
From mdxhealth
Via GlobeNewswire
TD SYNNEX, Albertsons And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday. 
Via Benzinga
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) shares jumped 58% to $1.88 after the company reported better-than-expected second-quarter financial results. 
Via Benzinga
Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Gainers PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) shares surged 46.7% to $0.64 in pre-market trading after gaining 6% on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders should watch on Thursday morning! 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.